Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Alejandro Escobar-Peso"'
Publikováno v:
Antioxidants, Vol 12, Iss 12, p 2102 (2023)
Acute ischemic stroke constitutes a health challenge with great social impact due to its high incidence, with the social dependency that it generates being an important source of inequality. The lack of treatments serving as effective neuroprotective
Externí odkaz:
https://doaj.org/article/89a1b60ff32741968535e80ccfd00415
Autor:
José M. Alonso, Alejandro Escobar-Peso, Israel Fernández, Alberto Alcázar, José Marco-Contelles
Publikováno v:
Pharmaceuticals, Vol 15, Iss 11, p 1363 (2022)
In our search for new neuroprotective agents for stroke therapy to improve the pharmacological profile of the compound quinolylnitrone QN23, we have prepared and studied sixteen new, related and easily available quinolylnitrones. As a result, we have
Externí odkaz:
https://doaj.org/article/57e9af1f94d34c99a91887172af4e606
Autor:
Emma Martínez-Alonso, Alejandro Escobar-Peso, Alicia Aliena-Valero, Germán Torregrosa, Mourad Chioua, Rocío Fernández-Serra, Daniel González-Nieto, Youness Ouahid, Juan B. Salom, Jaime Masjuan, José Marco-Contelles, Alberto Alcázar
Publikováno v:
Antioxidants, Vol 11, Iss 6, p 1186 (2022)
Nitrones are encouraging drug candidates for the treatment of oxidative stress-driven diseases such as acute ischemic stroke (AIS). In a previous study, we found a promising quinolylnitrone, QN23, which exerted a neuroprotective effect in neuronal ce
Externí odkaz:
https://doaj.org/article/5d0ddac6fefa4f3ebcbbfac8601dd46c
Autor:
José M. Alonso, Alejandro Escobar-Peso, Alejandra Palomino-Antolín, Daniel Diez-Iriepa, Mourad Chioua, Emma Martínez-Alonso, Isabel Iriepa, Javier Egea, Alberto Alcázar, José Marco-Contelles
Publikováno v:
Pharmaceuticals, Vol 14, Iss 9, p 861 (2021)
Cerebrovascular diseases such as ischemic stroke are known to exacerbate dementia caused by neurodegenerative pathologies such as Alzheimer’s disease (AD). Besides, the increasing number of patients surviving stroke makes it necessary to treat the
Externí odkaz:
https://doaj.org/article/4cea36c23b4c4e4c8f6cfe07236bf2f7
Autor:
Emma Martínez-Alonso, Alejandro Escobar-Peso, Maria I. Ayuso, Rafael Gonzalo-Gobernado, Mourad Chioua, Juan J. Montoya, Joan Montaner, Israel Fernández, José Marco-Contelles, Alberto Alcázar
Publikováno v:
Antioxidants, Vol 9, Iss 4, p 291 (2020)
Nitrones have a well-recognized capacity as spin-traps and are considered powerful free radical scavengers, which are two important issues in hypoxia-induced oxidative stress and cell death in brain ischemia. Consequently, nitrones have been proposed
Externí odkaz:
https://doaj.org/article/c7438302baec4b70b89fab050e8db6f2
Autor:
Emma Martínez-Alonso, Alejandro Escobar-Peso, Natalia Guerra-Pérez, Marcel Roca, Jaime Masjuan, Alberto Alcázar
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 9; Pages: 8246
Transient cerebral ischemia induces neuronal degeneration, followed in time by secondary delayed neuronal death that is strongly correlated with a permanent inhibition of protein synthesis in vulnerable brain regions, while protein translational rate
Autor:
Emma Martínez-Alonso, Natalia Guerra-Pérez, Alejandro Escobar-Peso, Lorena Peracho, Rocío Vera-Lechuga, Antonio Cruz-Culebras, Jaime Masjuan, Alberto Alcázar
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 1830, p 1830 (2022)
International Journal of Molecular Sciences; Volume 23; Issue 3; Pages: 1830
E-Prints Complutense. Archivo Institucional de la UCM
Universitad de Lleida
International Journal of Molecular Sciences; Volume 23; Issue 3; Pages: 1830
E-Prints Complutense. Archivo Institucional de la UCM
Universitad de Lleida
Ischemic strokes are caused by a reduction in cerebral blood flow and both the ischemic period and subsequent reperfusion induce brain injury, with different tissue damage depending on the severity of the ischemic insult, its duration, and the partic
Autor:
Alejandro Escobar-Peso, Emma Martínez-Alonso, Alberto Alcázar, Natalia Guerra-Pérez, Jaime Masjuan, Ignacio Regidor
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 10327, p 10327 (2021)
International Journal of Molecular Sciences
Volume 22
Issue 19
E-Prints Complutense. Archivo Institucional de la UCM
instname
International Journal of Molecular Sciences
Volume 22
Issue 19
E-Prints Complutense. Archivo Institucional de la UCM
instname
Cerebral ischemia induces an inhibition of protein synthesis and causes cell death and neuronal deficits. These deleterious effects do not occur in resilient areas of the brain, where protein synthesis is restored. In cellular stress conditions, as b
Autor:
Alberto Alcázar, Emma Martínez-Alonso, Isabel Iriepa, Alejandra Palomino-Antolín, Jose M. Alonso, Mourad Chioua, Daniel Diez-Iriepa, Alejandro Escobar-Peso, José Marco-Contelles, Javier Egea
Publikováno v:
Pharmaceuticals, Vol 14, Iss 861, p 861 (2021)
Digital.CSIC. Repositorio Institucional del CSIC
instname
Pharmaceuticals
Volume 14
Issue 9
Digital.CSIC. Repositorio Institucional del CSIC
instname
Pharmaceuticals
Volume 14
Issue 9
Cerebrovascular diseases such as ischemic stroke are known to exacerbate dementia caused by neurodegenerative pathologies such as Alzheimer’s disease (AD). Besides, the increasing number of patients surviving stroke makes it necessary to treat the
Autor:
María Irene Ayuso, Alejandro Escobar-Peso, Mourad Chioua, Dimitra Hadjipavlou-Litina, Juan J. Montoya, Lourdes Infantes, Alberto Alcázar, Joan Montaner, José Marco-Contelles, Rafael Gonzalo-Gobernado, Emma Martínez-Alonso
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
instname
We describe herein the synthesis and neuroprotective capacity of an array of 31 compounds comprising quinolyloximes, quinolylhydrazones, quinolylimines, QNs, and related heterocyclic azolylnitrones. Neuronal cultures subjected to oxygen-glucose depri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e426a88d68f382af7cb3a682fa46d47
http://hdl.handle.net/10261/185351
http://hdl.handle.net/10261/185351